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Abstract:  
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 Last August, the CDC updated its recommendations regarding what populations are at 
risk and should get tested for the hepatitis C virus, adding that those born from 1945 through 
1965, or “baby boomers”, should receive a one-time Hepatitis C test due to the disproportionate 
number of cases in the age group.  My goal was to identify which states are in compliance with 
these recommendations, and how many include the latest update.  I collected data by searching 
specific terms about Hepatitis C within each state’s department of health website; I found that 
34% of states were fully in line with the CDC and so far 54% of states include that baby boomers 
should get tested. In addition, the majority of state sites have links to the CDC’s Hepatitis C 
pages and over 2/3 of states have some sort of guidelines or prevention plan dedicated to the 
virus.    
 
Introduction:  
 
 Hepatitis C is a contagious liver disease resulting from the hepatitis C virus (HCV) that 
can be either acute or chronic.  Acute HCV infection occurs within the first 6 months of exposure 
to the virus, and about 75% - 85% of these cases become chronic. Chronic HCV infection is a 
more severe version of the virus which can lead to severe liver problems over time.1  According 
to the CDC, 60% - 70% of HCV-positive persons will develop chronic liver disease, 5% - 20% 
of HCV-positive persons will develop cirrhosis after 20 to 30 years of having the virus, and 1% - 
5% of HCV-positive persons will end up dying due to their chronic infection, from either liver 
                                                      
1 "Hepatitis C Information for the Public: Hepatitis C FAQs for the Public." Centers for Disease Control and 
Prevention. Centers for Disease Control and Prevention, 22 Oct. 2012. Web. Jan 2013. 
<http://www.cdc.gov/hepatitis/C/cFAQ.htm#overview>.  
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cancer or cirrhosis.2  HCV is the most common chronic bloodborne infection in the United 
States3 and has an estimated prevalence of 3.2 million people in this country alone;4 this number 
is well over the estimated 1.2 million HIV-infected persons in the U.S..5   
 The majority of the CDC’s current recommendations for HCV testing were published in 
1998; the guidelines grouped factors by those who should be tested based on their risk for 
infection, those who should be tested based on a recognized exposure, those who should not be 
tested (unless they have a risk factor), and those for whom the need for testing is uncertain.  No 
new groups or risk factors were added to the recommendations until 2009, when the guidelines 
were updated to include that all HIV-infected patients should be tested for HCV.  The most 
recent update to the CDC guidelines came in August 2012, when Recommendations for the 
Identification of Chronic Hepatitis C Virus Infection Among Persons Born During 1945-1965 
was published; as indicated by the title, it is now recommended that all persons born from 1945 
through 1965 receive one-time testing for HCV “without prior ascertainment of HCV risk 
factors”.6  This update is extremely important considering that as much as 75% of HCV-infected 
                                                      
2 "Hepatitis C Information for Health Professionals: Hepatitis C FAQs for Health Professionals." Centers for Disease 
Control and Prevention. Centers for Disease Control and Prevention, 7 May 2013. Web. Jan. 2013. 
<http://www.cdc.gov/hepatitis/hcv/hcvfaq.htm>. 
3 Chen, Stephen, and Timothy Morgan. "The Natural History of Hepatitis C Virus (HCV) Infection." International 
Journal of Medical Sciences. 3.2 (2006): 47-52. Web. 17 May. 2013. 
<http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1415841/>. 
4 Ibid 2.  
5 "U.S. Statistics: HIV in the United States." AIDS.gov. U.S. Department of Health & Human Services, 6 Jun 2012. 
Web. 17 May 2013. <http://aids.gov/hiv-aids-basics/hiv-aids-101/statistics/>. 
6 "Hepatitis C Information for Health Professionals: Testing Recommendations for Chronic Hepatitis C Virus 
Infection." Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 14 May 2013. 
Web. Jan. 2013. <http://www.cdc.gov/hepatitis/HCV/GuidelinesC.htm>. 
4 
persons fall within that age group and due to the asymptomatic nature of the disease, a 
significant number of these people are unaware of their infection.7   
 Although the disease can be severe if left undiagnosed and untreated for a long period of 
time, new promising medications are becoming available that make the identification of the virus 
critical in improving the health and lives of infected individuals.  Treatment for HCV in the past 
has largely consisted of injecting peginterferon, a general immune stimulant with toxic side 
effects in high doses often required for treatment, preventing many from being able to use it.8  A 
recent study has revealed the success of using a combination of oral sofosbuvir and ribavirin, 
antiviral drugs that work to attack HCV and prevent it from replicating, in treating and 
eventually eliminating the virus.9  
 The goal of my research was to determine what state health departments recommend for 
HCV testing compared to the CDC recommendations, how this information is presented publicly 
on state department of health websites, and the extent of interstate variation. 
 
Methods:  
 
 I began my research by educating myself more about Hepatitis C.  I looked up aspects 
including what the hepatitis C virus is, the history of the virus, whether it is treatable or curable 
and how, and statistics such as the prevalence and incidence of HCV in the United States.  I also 
spent some time going through the CDC’s pages on HCV and used the list of testing 
                                                      
7 "Hepatitis C." Viral Hepatitis Action Coalition. Viral Hepatitis Action Coalition, Inc., 2013. Web. April 2013. 
<http://www.viralhepatitisaction.org/hepatitis-c>. 
8 Blouin, Melissa Lutz. "New antiviral drugs clear Hepatitis C in patients without treatment options." University of 
Florida News. University of Florida , 26 Apr. 2013. Web. May 2013. <http://news.ufl.edu/2013/04/26/hep-nejm/>. 
9 Jacobson, Ira, Stuart Gordon, et. al. "Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment 
Options." The New England Journal of Medicine (2013): n. pag. Web. 
<http://www.nejm.org/doi/full/10.1056/NEJMoa1214854>.   
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recommendations10 found in the section for health professionals to base the organization of my 
research tables on.  To prepare for collecting data from each state, I created two spreadsheets, 
Table 1 and Table 2.  Table 1: “References by State” consists of all the websites I used to obtain 
my information, functioning as reference list categorized by state, and Table 2: “Hepatitis C Risk 
Factors by State” lists the various risk factors and groups mentioned in the CDC 
recommendations and how each state includes them in their own recommendations. The table is 
coded using 0, 1, and 9 to represent that the state does not recommend testing for the risk factor, 
does recommend testing, or if the need for testing is considered uncertain respectively (0 = 
testing not recommended, 1 = testing recommended, and 9 = unsure of need for testing).  
 Initially I spent a lot of time looking for state legislation on HCV requirements, but found 
very little in terms of who is and isn’t included in testing. I shifted my focus to state 
recommendations, using the information found on each state’s department of health website. A 
number of states have nongovernmental organizations dedicated to HCV, but I stuck only to 
what was found to be recommended by the states, not the other groups.  
 I was also interested in figuring out the recommendations for counseling those getting 
tested for or who have HCV. I divided counseling into “pre-test counseling”, “post-test 
counseling”, and “risk reduction counseling” and created Table 3: “Hepatitis C Guidelines, 
Counseling, and Plans by State” to add the information for each state.  After going through a few 
states, I decided to include additional relevant information to Table 3: whether the state has 
guidelines or a strategic plan for HCV, if the state website has separate pages or links for health 
care professionals, and whether or not there was information about training to provide counseling 
for HCV.  Like with Table 2, Table 3 is coded using 0, 1, and 9, here 0 indicates the variable is 
                                                      
10 Ibid 6.  
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not included, 1 that it is included, and 9 was used only in the strategic plan section to indicate if 
the state had a plan that included Hepatitis but was not dedicated to it.  
 The terms used to search the state department of health websites were consistent for 
every state, though some did not require all of the terms be searched since the information was 
easily found through pages I had already accessed.  To complete Table 2, I searched the terms 
“hepatitis c”, “hepatitis”, “hepatitis c testing”, and if I couldn’t find the right data from those, 
“hepatitis c screening”.  Table 3 required a bit more work to complete, and the search terms used 
were:  
• “hepatitis c counseling”,  
• “hepatitis c provider”,  
• “hepatitis c professional”,  
• “hepatitis c training”,  
• “counseling training” (within the HCV pages),  
• “hepatitis c strategic plan”,   
• “hepatitis c prevention plan”,  
• “hepatitis c guidelines”, and  
• “counseling guidelines”.  
I chose the terms based first off of what I was specifically looking for, then played with the 
wording to ensure nothing was missed, an example being that I had to search for “providers” as 
well as “professionals” because some websites only include one of the terms but are meant for 
the same group of people.   
 Once data collection for Tables 2 and 3 was complete, the information within them was 
used to create the remaining tables.  Table 4: “Percent of States Recommending Testing for 
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Specific Risk Groups”, Table 5: “Level of State Compliance with CDC Recommendations for 
HCV Testing (excluding where the CDC is “unsure”)”, and Table 6: “State Compliance With 
CDC Recommendations Including Factors for Which the CDC is Uncertain of the Need for 
Testing” were each created using Table 2, and Table 7: “State Recommendations Listed on 
Department of Health Websites” was created using Table 3.  These additional tables are 
summaries of the other two that are easier for viewing.    
 
Results:  
 
 Table 4, “Percent of States Recommending Testing for Specific Risk Groups”, lists all of 
the risk groups mentioned in the CDC guidelines, grouped by whether the CDC recommends 
they be offered testing, the CDC recommends they not be tested unless they have another risk 
factor, or the CDC is unsure whether testing is needed.  The list of risk groups is on the left, and 
the right columns indicate the fraction of states (N=50, excluding District of Colombia) that 
recommend testing or are unsure for each category.  Some interesting findings from the table 
include:  
• More than half the states, 54%, have already added that those born from 1945 through 
1965 should be tested for HCV.  
• For the following risk groups: “current injecting drug users”, “ever injected drugs, 
including only once or many years ago”, “received a transfusion of blood, blood 
components, or an organ transplant before July 1992”, and “healthcare, emergency 
medical, and public safety workers after needle sticks, sharps, or mucosal exposures to 
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HCV-positive blood”, 100% of states were in compliance for recommending these groups 
get tested for HCV.  
• For the following risk groups: “healthcare, emergency medical, and public safety 
workers”, “pregnant women” and “the general population”, 100% of states were in 
compliance for stating these groups do not need testing unless they also have another risk 
factor.   
• Only one group of those for whom testing is not recommended by the CDC had any 
discrepancy and that was “household (nonsexual) contacts of HCV-positive persons”, 
where 10% of states said testing is recommended, but this is mostly because those states 
overlapped this category with those who may become exposed to blood through sharing 
objects such as razors or nail clippers.  
• Of the risk groups where the CDC is uncertain of the need for testing, only two of the 
factors “recipients of transplanted tissue” and “persons with a history of tattooing or body 
piercing - done with sterile materials or unspecified” had no states recommend that they 
be tested.  
• The risk groups in the category “Risk Groups with Unclear Testing Recommendations 
from the CDC” were the only groups to possess any states that are uncertain of whether 
testing is needed.   
 Table 5, “Level of State Compliance with CDC Recommendations for HCV Testing 
(excluding where the CDC is “unsure”)”, lists the levels of state compliance, including the 
number of factors differing from the CDC guidelines in parenthesis; the percent of states at each 
level; and the specific states falling into each category.  The compliance levels consist of “Total 
(0)”, “High (1 or 2)”, “Moderate (3 or 4)”, and “Low (5+)”.  Fortunately, the percentage of states 
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at each level were in descending order with the largest amount of states, 34%, being in total 
compliance and the smallest group of states, 18%, having the least compliance.  
 Table 6, “State Compliance With CDC Recommendations Including Factors for Which 
the CDC is Uncertain of the Need for Testing”, categorizes states based off of the number of risk 
groups for which they consider the need for testing to be uncertain out of all of the groups for 
which the CDC is unsure of.  From this table, it can be seen that 14% of states are in 100% 
compliance with the CDC’s recommendations for HCV testing based upon risk groups, including 
matching up all the groups where the CDC considers the need for testing uncertain.  An 
additional 6% of states included one or two of the uncertain risk groups as such, but no states 
included more than that that didn’t list every other uncertain risk group.  The table includes 
Nebraska as one of the states in complete compliance, but it should be noted that the state’s 
guidelines recommend that those tattooed or pierced with non-sterile materials should get tested 
and that if the materials used were sterile the need is uncertain; the CDC does not make the 
distinction between sterile and non-sterile tattoos and piercings so I am still considering 
Nebraska to be fully in line since if the CDC did specify, it is likely that it would show the same 
stance as Nebraska.  
 Table 7, “State Recommendations Listed on Department of Health Websites”, lists 
numerous components about what is included within each state’s department of health pages on 
HCV or what the state recommends other than the risk groups found in Table 4.  Some important 
takeaways from this table are:  
• The majority of states, 88%, include one or more links to the CDC’s HCV pages.  
• More than half of states, 56%, have some form of Strategic, Harm Reduction, or 
Prevention Plan created to address HCV or all forms of Viral Hepatitis, and 34% of states 
10 
have separate written guidelines on testing and counseling.  The plans tended to include 
sections about increasing awareness of the virus, expanding prevention education, the 
involvement of counseling, and the need for training among health care workers about 
HCV and other forms of hepatitis.  The guidelines as a whole included more details 
specifically on the recommended counseling procedures.   
• 30% of states currently that have neither plans nor guidelines regarding HCV.  
• Referring back to Table 3 to see specific states, I found that every state that recommends 
pre-test counseling also recommends post-test counseling.  
• When looking for what counseling or training to provide it entails, there were multiple 
cases where I would have needed to have an account with the site to view the 
information.  
• Through the data collection process, I found that the majority of state HCV websites 
include either attached PDFs or lists within the site of locations within the state where 
one could go for testing, counseling, treatment, or find a support group.  They locations 
are generally divided by either county or purpose (counseling centers, treatment center, 
etc.).  
 
Discussion:  
 
 To recap, my research goals were to determine state compliance with the CDC 
recommendations for Hepatitis C testing, find how this information was presented by state 
department of health websites, and compare variations among states.  I obtained my data from 
each state’s department of health websites, going through each twice; the first time looking for 
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testing recommendations and the second time looking for details on state counseling guidelines 
and prevention plans.  Some of the most important findings include that over half of states have 
already added that those born through 1945 and 1965 get tested; most states have links in their 
Hepatitis C information to the CDC website, an easy way to stay accurate; over 2/3 of states 
include some form of guidelines or strategic plans dedicated to Hepatitis (some covering all 
forms of Hepatitis, and others specifically Hepatitis C); and 60% of states have 2 or fewer 
discrepancies from the CDC’s risk group categories.  An observation I came across while 
searching for data is that in regards to recommending specific groups, states did often make an 
effort to inform the public if there had been an HCV outbreak in a hospital or similar setting and 
promote that anyone who may have been in the department within a given time frame should 
receive testing, help often boosted through media attention.   
 I found it interesting that a number of states had merged the Hepatitis section with their 
pages on HIV and sometimes STDs as well, but it made sense upon learning about the CDC’s 
relatively new Program Collaboration and Service Integration (PCSI) initiative.  According to 
the CDC, PCSI “is a mechanism for organizing and blending interrelated health issues, activities, 
and prevention strategies to facilitate comprehensive delivery of services”.11  The fact that 
multiple states have already merged these areas shows that the states either agree with the 
consolidation and or moving towards it to be better aligned with the CDC, or that a number of 
them already possessed that mindset and the CDC is taking their example.     
 In an article published in 2009 entitled “Consistency of State Statutes With the Centers 
for Disease Control and Prevention HIV Testing Recommendations for Health Care Settings”, 
                                                      
11 "Program Collaboration and Service Integration (PCSI) at NCHHSTP: About PCSI." Centers for Disease Control 
and Prevention. Centers for Disease Control and Prevention, 13 Dec. 2012. Web. May 2013. 
<http://www.cdc.gov/nchhstp/programintegration/About.htm>.  
12 
A.P. Mahajan et. al. discussed the CDC’s 2006 guidelines on HIV testing, how states are 
implementing the update, and whether state legislation surrounding HIV procedures hampered 
their ability to successfully implement the guidelines.  The update consisted of recommending 
that “all patients in all health care settings be offered opt-out HIV screening without separate 
written consent and prevention counseling”;12 the change designed to increase the number of 
people getting tested and reduce the boundary of stigmatization over potential risk factors.  An 
interesting inclusion in the recommendations is that personalized HIV risk reduction counseling 
should not be required for patients getting tested and that they should instead be offered a referral 
for counseling.13  The results showed that 68% of states have statutory frameworks that are either 
in-line or neutral to the CDC recommendations, and so in essence are compliant with the 
recommendations, and that the remaining states would need legislation changes in order to be 
able to fully implement the recommendations.  Additionally, 9 of the states with policies 
consistent with the CDC were made so recently, indicating that more states are likely to follow 
this trend.14  The finding of 68% is double the amount of states fully compliant with the CDC’s 
recommendations for HCV testing and risk groups, but the number of states compliant with the 
CDC’s HIV testing may be lower than 68% since the percentage includes states with neutral 
policies and so they may or may not be being implemented there.  A positive of there being 
fewer formal state policies on Hepatitis C is that there are fewer potential measures that would 
prevent the implementation of CDC recommendations, but the lack of legal attention has 
                                                      
12 Mahajan, Anish, Lara Stemple, et al. "Consistency of State Statutes With the Centers for Disease Control and 
Prevention HIV Testing Recommendations for Health Care Settings." Annals of Internal Medicine. 150.4 (2009): 
263. Print. 
13 Ibid 12, pp. 264.  
14 Ibid 12, pp. 265.  
13 
negatives as well, for HCV may then get less attention from policymakers and lobbyists who 
would have some power in making sure the CDC guidelines got enforced.   
 Hepatitis C has been deemed a “silent epidemic” due to the fact that the damage the virus 
does to one’s liver can go unnoticed for well over a decade, leading to severe ailments such as 
chronic liver disease, cirrhosis, liver cancer, and liver failure15.  With a large number of cases 
being contracted in the 1970s and 1980s, is now critical for the “baby boomer generation”, born 
from 1945 through 1965, to receive testing for HCV since those in that group who unknowingly 
have the virus are likely to already have moderate to extensive liver damage, and the sooner 
these people get treatment the more likely they are to recover or gain some control over the virus. 
Considering that this age group consists of up to 75% of HCV cases in the U.S. and that a cure is 
possible, treating this population could play a substantial role in minimizing prevalence of HCV.   
 There were some limitations that may have altered or restricted my research.  The time 
period available prevented me from looking into some factors further, and the fact that I added 
on some variables that I did not initially realize I would be looking for did not make for the most 
efficient research process.  I began my work looking for legislation or formal policies directed 
towards Hepatitis C due the presence of several policies dedicate to HIV.  There are some laws 
that include Hepatitis, such as those regarding communicable diseases, but they are more 
directed towards disease reporting, workers compensation post-exposure, and prisoners’ rights to 
testing and treatment rather than risk groups for whom testing should be directed or counseling 
requirements; I think further research would be to examine policies relating to HCV more in 
depth and compare them among the states.   
                                                      
15 The C. Everett Koop Institute. " The Silent Epidemic: Hepatitis C." Hepatitis C: An Epidemic for Anyone. 
Dartmouth-Hitchcock Medical Center, 2013 Web. March 2013. 
<http://www.epidemic.org/thefacts/hepatitisc/silentEpidemic/>.   
14 
Future research should be done using additional search terms such as “follow-up”, 
because along the way I realized that some recommendations included checking up on patients 
over the course of time-once they had tested positive for HCV-to provide counseling or suggest 
treatments.  The terminology used on each state’s website differed slightly, sometimes making it 
difficult to understand or categorize the information into my tables, an example being the 
distinction between at-risk groups versus those for whom testing is definitely recommended.  
Another aspect that should be explored is if any state health departments that may not be as up-
to-date with their recommendations, or even including those that are, rely on additional 
nongovernmental or separate agencies more focused on HCV to create guidelines, spread 
awareness, or provide risk reduction education resources.   
 Hepatitis C is a significant issue in the United States, affecting about 3.2 million 
Americans, yet it is generally kept under the radar of attention from the general public.  New 
research, especially within the last decade, promising improved medications and an increased 
chance of being completely cured, makes identifying HCV-positive individuals a more relevant 
task now than ever.  It seems that along with the CDC’s release of the latest testing 
recommendations, a growing number of studies and attention has been given to the virus and 
potential treatment options, so hopefully the states falling short on compliance with the 
guidelines will soon be inspired to follow suit and make its residents more aware of this silent 
epidemic.   
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Alabama 1 1 0 1 1 1 1 1 1 1 1 0 1 
Alaska 1 1 0 1 1 1 1 1 1 1 1 0 1 
Arizona 1 1 0 1 1 0 1 1 1 1 1 0 0 
Arkansas 1 1 0 1 1 1 0 0 1 1 1 0 1 
California 1 1 0 1 1 1 1 1 1 1 1 0 1 
Colorado 1 1 0 1 1 1 1 1 1 1 1 0 1 
Connecticut 1 1 0 1 1 1 1 1 1 1 1 0 1 
Delaware 1 1 1 1 1 0 0 0 1 1 1 0 1 
Florida 1 1 0 1 0 0 0 0 1 1 1 0 1 
Georgia 1 1 1 0 1 1 1 1 1 1 1 0 1 
Hawaii 1 1 1 0 0 0 0 0 1 1 1 0 1 
Idaho 1 1 0 1 1 1 1 1 1 1 1 0 1 
Illinois 1 1 0 1 1 1 1 1 1 1 1 0 1 
Indiana 1 1 0 1 1 1 1 1 1 1 1 0 1 
Iowa 1 1 0 1 1 1 0 0 1 1 1 0 1 
Kansas 1 1 0 1 1 0 1 1 1 1 1 0 1 
Kentucky 1 1 0 1 1 1 0 0 1 1 1 0 1 
Louisiana 1 1 1 1 1 0 0 0 1 1 1 0 1 
Maine 1 1 0 1 1 1 1 1 1 1 1 0 1 
Maryland 1 1 0 1 1 0 1 1 1 1 1 0 1 
Massachusetts 1 1 9 1 1 1 1 1 1 1 1 0 1 
Michigan 1 1 1 1 1 1 0 0 1 1 1 0 1 
Minnesota 1 1 9 1 1 1 1 1 1 1 1 0 1 
Mississippi 1 1 0 1 1 1 1 1 1 1 1 0 1 
Missouri 1 1 9 1 1 1 1 1 1 1 1 0 1 
Montana 1 1 0 1 1 1 1 1 1 1 1 0 1 
Nebraska 1 1 9 1 1 1 1 1 1 1 1 0 1 
Nevada 1 1 0 1 1 1 1 1 1 1 1 0 1 
New 
Hampshire 
1 1 0 1 1 1 1 1 1 1 1 0 1 
New Jersey 1 1 0 1 1 1 0 0 1 1 1 0 0 
New Mexico 1 1 9 1 1 1 1 1 1 1 1 0 1 
New York 1 1 0 1 1 1 1 1 1 1 1 0 1 
North Carolina 1 1 0 1 1 1 0 0 1 1 1 0 1 
North Dakota 1 1 0 1 1 0 0 0 1 1 1 0 1 
Ohio 1 1 1 0 0 0 0 0 1 1 1 0 0 
Oklahoma 1 1 0 1 1 0 0 0 1 1 1 0 1 
Oregon 1 1 0 1 1 1 1 1 1 1 1 0 1 
Pennsylvania 1 1 0 1 1 0 1 1 1 1 1 0 1 
Rhode Island 1 1 1 1 1 0 0 0 1 1 1 0 1 
South Carolina 1 1 9 1 1 1 1 1 1 1 1 0 1 
South Dakota 1 1 9 1 1 1 1 1 1 1 1 0 1 
Tennessee 1 1 1 1 0 0 0 0 1 1 1 0 0 
Texas 1 1 0 1 1 1 0 0 1 1 1 0 1 
Utah 1 1 0 1 1 0 1 1 1 1 1 0 1 
Vermont 1 1 0 1 1 1 0 0 1 1 1 0 1 
Virginia 1 1 0 0 1 0 0 0 1 1 1 0 1 
Washington 1 1 0 1 1 1 1 1 1 1 1 0 1 
West Virginia 1 1 0 1 1 1 1 1 1 1 1 0 1 
Wisconsin 1 1 0 1 1 1 1 1 1 1 1 0 1 
Wyoming 1 1 0 0 1 1 0 0 1 1 1 0 0 
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Table 2. Hepatitis C Risk Factors by State, continued from page 20.  
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Alabama 0 0 0 0 0 0 1 0 1 1 0 0 1 0 
Alaska 0 0 0 0 0 0 1 0 1 1 0 0 1 0 
Arizona 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
Arkansas 0 0 0 0 0 0 1 0 0 0 0 0 1 0 
California 0 0 0 0 0 0 1 0 1 1 0 1 1 0 
Colorado 0 0 0 0 0 0 1 0 1 0 0 1 1 0 
Connecticut 0 0 0 0 0 0 9 0 1 1 0 0 1 0 
Delaware 0 0 0 1 1 0 1 0 0 1 0 0 0 0 
Florida 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
Georgia 0 0 1 0 1 0 1 0 1 0 0 0 1 0 
Hawaii 0 0 1 1 1 0 1 0 0 1 0 0 1 0 
Idaho 0 0 9 0 0 0 9 0 1 1 0 0 1 0 
Illinois 0 0 9 0 0 0 9 0 0 0 0 0 1 0 
Indiana 0 1 1 0 1 0 1 0 0 0 0 1 1 0 
Iowa 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
Kansas 0 0 0 0 0 0 1 0 1 0 0 0 1 0 
Kentucky 0 0 1 0 1 0 0 0 0 0 0 0 1 0 
Louisiana 0 1 1 1 1 0 0 0 0 1 0 0 1 0 
Maine 0 0 0 0 0 0 1 0 1 1 0 0 1 0 
Maryland 0 0 0 1 1 0 0 0 1 0 0 0 0 0 
Massachusetts 0 0 9 9 9 9 9 9 1 1 0 0 1 0 
Michigan 0 1 1 1 1 0 1 0 1 1 0 1 1 0 
Minnesota 0 0 9 9 9 9 9 9 1 1 0 0 1 0 
Mississippi 0 0 0 0 0 0 1 0 1 1 0 0 1 0 
Missouri 0 0 9 9 9 9 9 9 1 1 0 0 1 0 
Montana 0 0 0 0 0 0 0 0 1 1 0 0 1 0 
Nebraska 0 0 9 9 9 9 1 9 1 1 0 1 1 0 
Nevada 0 0 0 0 0 0 1 0 1 0 0 1 1 0 
New 
Hampshire 
0 1 0 0 0 0 1 0 0 1 0 0 1 
0 
New Jersey 0 0 0 0 1 0 0 0 1 1 0 0 1 0 
New Mexico 0 0 9 9 9 9 9 9 1 1 0 0 1 0 
New York 0 0 0 0 0 0 1 0 1 1 0 1 1 0 
North 
Carolina 
0 0 0 1 1 0 0 0 1 1 0 0 1 
0 
North Dakota 0 0 0 0 0 0 1 0 1 0 0 0 1 0 
Ohio 0 0 1 0 0 0 1 0 1 1 0 1 1 0 
Oklahoma 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
Oregon 0 0 1 0 0 0 0 0 1 0 0 0 1 0 
Pennsylvania 0 0 1 0 0 0 1 0 1 1 0 1 0 0 
Rhode Island 0 1 1 0 1 0 0 0 0 0 0 0 1 0 
South 
Carolina 
0 0 9 9 9 9 9 9 1 1 0 0 1 
0 
South Dakota 0 0 9 9 9 9 9 9 1 1 0 0 1 0 
Tennessee 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
Texas 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
Utah 0 0 0 0 0 0 1 0 1 1 0 0 1 0 
Vermont 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
Virginia 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
Washington 0 0 1 0 0 0 1 0 1 0 0 0 1 0 
West Virginia 0 0 1 0 0 0 1 0 1 1 0 1 1 0 
Wisconsin 0 0 1 0 0 0 0 0 0 0 0 0 1 0 
Wyoming 0 0 0 0 0 0 0 0 1 0 0 0 1 0 
22 
Table 3. Hepatitis C Guidelines, Counseling, and Plans by State  
STATE Guidelines 
Separate Page or Section 
of Links for 
Professionals/Health 
Care Providers 
Training 
Links/Info 
Pre-test 
counseling 
provided 
Risk 
Reduction 
Counseling 
Post-test 
counseling 
provided 
Strategic, 
Harm 
Reduction, 
or 
Prevention 
Plan 
Alabama 0 0 0 0 0 0 0 
Alaska 0 0 0 0 0 0 0 
Arizona 0 1 1 0 0 1 9 
Arkansas 0 0 0 0 0 0 0 
California 0 1 0 0 0 1 0 
Colorado 1 1 1 1 1 1 1 
Connecticut 0 1 0 0 0 1 0 
Delaware 0 0 0 0 0 0 9 
Florida 0 0 1 0 1 1 1 
Georgia 1 1 0 1 1 1 1 
Hawaii 0 1 1 1 1 1 1 
Idaho 0 1 1 0 0 1 0 
Illinois 0 0 0 0 0 0 0 
Indiana 0 1 0 1 1 1 1 
Iowa 0 0 1 1 1 1 1 
Kansas 1 1 0 1 1 1 0 
Kentucky 0 1 0 0 0 1 0 
Louisiana 1 0 0 0 1 1 0 
Maine 0 0 1 1 1 1 1 
Maryland 1 0 1 1 1 1 1 
Massachusetts 1 1 0 0 0 1 0 
Michigan 0 0 0 0 0 0 1 
Minnesota 0 1 0 0 0 1 1 
Mississippi 0 0 0 1 1 1 0 
Missouri 0 1 0 0 0 0 0 
Montana 0 0 0 0 0 0 0 
Nebraska 0 0 0 1 1 1 1 
Nevada 1 0 0 1 1 1 1 
New Hampshire 0 0 0 1 1 1 1 
New Jersey 0 0 0 1 1 1 1 
New Mexico 1 0 1 1 1 1 1 
New York 1 0 1 1 1 1 1 
North Carolina 0 1 1 0 0 0 0 
North Dakota 1 1 1 1 1 1 0 
Ohio 0 0 0 1 1 1 1 
Oklahoma 0 0 0 0 0 0 0 
Oregon 1 0 0 0 1 1 0 
Pennsylvania 1 0 1 1 1 1 0 
Rhode Island 1 1 0 1 1 1 1 
South Carolina 0 0 1 1 0 1 1 
South Dakota 1 0 0 1 1 1 0 
Tennessee 1 0 0 1 1 1 1 
Texas 0 0 0 1 1 1 1 
Utah 0 1 0 1 1 1 1 
Vermont 0 1 0 1 1 1 1 
Virginia 0 0 0 1 1 1 1 
Washington 1 1 0 1 1 1 1 
West Virginia 0 1 0 0 0 1 0 
Wisconsin 1 1 0 1 1 1 1 
Wyoming 0 1 1 1 1 1 0 
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Table 4. Percent of States Recommending Testing for Specific Risk Groups 
Risk Group 
Percent of States 
Recommending 
Testing 
Percent of States 
Unsure if Testing is 
Needed 
Risk Groups Recommended for Testing by CDC 
Adults born during 1945 through 1965 54 0 
Current injecting drug users 100 0 
Ever injected drugs, including only once or many years 
ago 
100 0 
Received clotting factor concentrates produced before 
1987 
90 0 
Were ever on long-term hemodialysis 92 0 
Have persistently abnormal alanine aminotransferase 
levels (ALT) 
70 0 
Received blood from a donor who later tested positive 
for HCV 
62 0 
Received a transfusion of blood, blood components, or 
an organ transplant before July 1992 
100 0 
Healthcare, emergency medical, and public safety 
workers after needle sticks, sharps, or mucosal 
exposures to HCV-positive blood 
100 0 
Children born to HCV-positive women 90 0 
Persons with HIV 64 0 
Risk Groups Not Recommended for Testing by CDC (unless they have an above risk factor) 
Healthcare, emergency medical, and public safety 
workers  0 0 
Pregnant women 0 0 
Household (nonsexual) contacts of HCV-positive 
persons 10 0 
General Population 0 0 
Risk Groups with Unclear Testing Recommendations from CDC 
Recipients of transplanted tissue (e.g. corneal, 
musculoskeletal, skin, ova, sperm) 
0 14 
Intranasal and non-injecting illegal drug users 16 14 
Persons with a history of tattooing or body piercing   
• Done with sterile materials or unspecified 0 14 
• Done with unsterile materials 46 18 
Persons with a history of multiple sex partners  28 14 
Persons with a history of sexually transmitted diseases 12 14 
Long-term steady sex partners of HCV-positive 
persons 
26 18 
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Table 5.  
Level of State Compliance with CDC Recommendations for HCV Testing (excluding where the 
CDC is "unsure") 
Compliance 
(factors different) 
% of 
States 
Specific States  
Total (0) 34 
Alabama, Alaska, California, Connecticut, Idaho, Maine, 
Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nebraska, 
New Mexico, New York, South Carolina, South Dakota, and West 
Virginia 
High (1 or 2) 26 
Colorado, Georgia, Illinois, Kansas, Maryland, Nevada, New 
Hampshire, North Carolina, Oregon, Pennsylvania, Utah, Washington, 
and Wisconsin 
Moderate (3 or 4)  22 
Arizona, Arkansas, Delaware, Indiana, Iowa, Kentucky, Michigan, 
New Jersey, North Dakota, Texas, and Vermont 
Low ( 5+)  18 
Florida, Hawaii, Louisiana, Ohio, Oklahoma, Rhode Island, Tennessee, 
Virginia, and Wyoming  
 
 
 
 
Table 6.  
State Compliance With CDC Recommendations Including Factors for Which the CDC is 
Uncertain of the Need for Testing 
# of the CDC’s Uncertain 
Factors Listed as Uncertain  
Percent of 
States 
Specific States 
All 14 
Massachusetts, Minnesota, Missouri, Nebraska*, New 
Mexico, South Carolina, and South Dakota 
1 or 2 6 Connecticut, Idaho, and Illinois  
3 to 5 0  
* Nebraska guidelines recommend those tattooed or pierced with non-sterile materials get tested and that 
if sterile it is uncertain, but the CDC makes no distinction between sterile and non-sterile 
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Table 7.  
State Recommendations Listed on Department of Health Websites Percent With 
Presence of a Strategic/Harm Reduction/Prevention Plan 56 
Presence of Written Guidelines (outside of plan) 34 
Presence of Both State Plans and Guidelines 20 
No State Plans or Guidelines 30 
Separate Webpages or Links for Healthcare Workers 44 
Presence of Links or Information for Healthcare Workers to Receive Training on 
Counseling  
30 
Risk Reduction Counseling Recommended  62 
Pre-test Counseling Recommended 58 
Post-test Counseling Recommended 80 
Pre- and Post-test Counseling Recommended 58 
Neither Pre- or Post-test Counseling Recommended 20 
Includes Link(s) to CDC 88 
* Michigan is listed in Table 3 as without having counseling recommendations, but is currently in process 
of making a plan/recommendations.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
